Clinical Trial Update: Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma [NA]

View source ↗

Summary

This document reports a clinical trial update testing metformin in combination with a tyrosine kinase inhibitor for Non-Small Cell Lung Cancer with TK mutations…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tyrosine kinase inhibitor (unspecified)
• metformin (metformin)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Non-Small Cell Adenocarcinoma, Tyrosine Kinase Mutation | NA | Status: UNKNOWN